Karine Guerrier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Karine Guerrier has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Richard J. Czosek
The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH, 45229, USA
6 shared publicationsDavid S. Spar
The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH, 45229, USA
4 shared publicationsJeffrey B. Anderson
The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH, 45229, USA
4 shared publicationsTimothy K. Knilans
The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH, 45229, USA
3 shared publications- Christopher Statile
Department of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
2 shared publications David Kwiatkowski
From the Department of Cardiology, Cincinnati Children's Hospital Medical Center, The Heart Institute, OH (K.G., R.J.C., D.S.S., J.B.A., T.K.K.); and Department of Cardiology, The Heart Center, Lucile Packard Children's Hospital, Palo Alto, CA (D.K.).
1 shared publication
Latest Publications
- 31 March 2016
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (5) , 946-952
Variation in Antiarrhythmic Management of Infants Hospitalized with Supraventricular Tachycardia: A Multi-Institutional Analysis
Supraventricular tachycardia (SVT) is the most frequent form of symptomatic tachyarrhythmia in infants. The purposes of this study were to describe practice patterns of the management of infants hospitalized with SVT and factors associated with 30-day hospital readmission. This was a multi-institutional, retrospective review of the pediatric health information system database of SVT hospitalizations from 2003 to 2013. High-volume centers (HVC) were defined as those at the upper quartile of admissions. Infants with an ICD-9 code of paroxysmal SVT were included. Antiarrhythmics investigated included amiodarone, atenolol, digoxin, esmolol, flecainide, procainamide, propafenone, propranolol, and sotalol. Frequency of antiarrhythmic use based on center volume was the primary end point. Rate of 30-day SVT readmission was the secondary end point. Analysis of factors associated with readmission was assessed by Chi-square analysis and expressed as odds ratio and 95 % confidence interval. A total of 851 patients (60 % male, 44 % neonates) were hospitalized at 43 hospitals. Propranolol, digoxin, and amiodarone were the most frequently utilized antiarrhythmics. HVCs represented 12 hospitals comprising 494 (58 %) patients. Although HVCs were more likely to utilize propranolol (OR 2.5, CI 1.5–4.1), there was no significant difference in the 30-day readmission rate between patients treated at HVCs versus non-HVCs (p = 0.9). The majority of infants with SVT are treated with a small number of antiarrhythmic medications during index hospitalization. Although hospital-to-hospital variation in antiarrhythmic choice exists, there appears to be no difference in readmission. The remaining practice variation may be related to intrinsic patient characteristics.
- 31 March 2016
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (5) , 946-952
Variation in Antiarrhythmic Management of Infants Hospitalized with Supraventricular Tachycardia: A Multi-Institutional Analysis
Supraventricular tachycardia (SVT) is the most frequent form of symptomatic tachyarrhythmia in infants. The purposes of this study were to describe practice patterns of the management of infants hospitalized with SVT and factors associated with 30-day hospital readmission. This was a multi-institutional, retrospective review of the pediatric health information system database of SVT hospitalizations from 2003 to 2013. High-volume centers (HVC) were defined as those at the upper quartile of admissions. Infants with an ICD-9 code of paroxysmal SVT were included. Antiarrhythmics investigated included amiodarone, atenolol, digoxin, esmolol, flecainide, procainamide, propafenone, propranolol, and sotalol. Frequency of antiarrhythmic use based on center volume was the primary end point. Rate of 30-day SVT readmission was the secondary end point. Analysis of factors associated with readmission was assessed by Chi-square analysis and expressed as odds ratio and 95 % confidence interval. A total of 851 patients (60 % male, 44 % neonates) were hospitalized at 43 hospitals. Propranolol, digoxin, and amiodarone were the most frequently utilized antiarrhythmics. HVCs represented 12 hospitals comprising 494 (58 %) patients. Although HVCs were more likely to utilize propranolol (OR 2.5, CI 1.5–4.1), there was no significant difference in the 30-day readmission rate between patients treated at HVCs versus non-HVCs (p = 0.9). The majority of infants with SVT are treated with a small number of antiarrhythmic medications during index hospitalization. Although hospital-to-hospital variation in antiarrhythmic choice exists, there appears to be no difference in readmission. The remaining practice variation may be related to intrinsic patient characteristics.
- 1 December 2015
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 8 (6) , 1460-1464
Short QT Interval Prevalence and Clinical Outcomes in a Pediatric Population
Background—: Risk associated with short QT interval has recently received recognition. European studies suggest a prevalence of 0.02% to 0.1% in the adult population, but similar studies in pediatric patients are limited. We sought to determine the prevalence of short QT interval in a pediatric population and associated clinical characteristics and outcomes. Methods and Results—: Retrospective review of an ECG database at a single pediatric institution. The database was queried for ECGs on patients ≤21 years with electronically measured QTc of 140 to 340 ms. Patients with QTc of 140 to 340 ms confirmed by a pediatric electrophysiologist were identified for chart review for associated clinical characteristics, symptoms, and outcome. Patients with and without symptoms were compared in an attempt to identify variables associated with outcome. The query included 272 504 ECGs on 99 380 unique patients. Forty-five patients (35 men, 76%) had QTc ≤340 ms, for a prevalence of 0.05%. Median age was 15 years (interquartile range, 2–17), median QT 330 ms (interquartile range, 280–360), and median QTc 323 ms (IQR, 313–332). Women had significantly shorter QTc compared with men (312 versus 323 ms; P =0.03). Two deaths were noted in chart review—one from respiratory failure and the second of unknown pathogenesis in a patient with dilated cardiomyopathy. Conclusions—: Short QT interval was a rare finding in this pediatric population, with a prevalence of 0.05%. Male predominance was identified, although the median QT interval was significantly shorter in women. There seem to be no unifying clinical characteristics for this pediatric patient cohort with short QT interval.
- 1 December 2015
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 8 (6) , 1460-1464
Short QT Interval Prevalence and Clinical Outcomes in a Pediatric Population
Background—: Risk associated with short QT interval has recently received recognition. European studies suggest a prevalence of 0.02% to 0.1% in the adult population, but similar studies in pediatric patients are limited. We sought to determine the prevalence of short QT interval in a pediatric population and associated clinical characteristics and outcomes. Methods and Results—: Retrospective review of an ECG database at a single pediatric institution. The database was queried for ECGs on patients ≤21 years with electronically measured QTc of 140 to 340 ms. Patients with QTc of 140 to 340 ms confirmed by a pediatric electrophysiologist were identified for chart review for associated clinical characteristics, symptoms, and outcome. Patients with and without symptoms were compared in an attempt to identify variables associated with outcome. The query included 272 504 ECGs on 99 380 unique patients. Forty-five patients (35 men, 76%) had QTc ≤340 ms, for a prevalence of 0.05%. Median age was 15 years (interquartile range, 2–17), median QT 330 ms (interquartile range, 280–360), and median QTc 323 ms (IQR, 313–332). Women had significantly shorter QTc compared with men (312 versus 323 ms; P =0.03). Two deaths were noted in chart review—one from respiratory failure and the second of unknown pathogenesis in a patient with dilated cardiomyopathy. Conclusions—: Short QT interval was a rare finding in this pediatric population, with a prevalence of 0.05%. Male predominance was identified, although the median QT interval was significantly shorter in women. There seem to be no unifying clinical characteristics for this pediatric patient cohort with short QT interval.
- 2 June 2015
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 26 (4) , 644-649
Risk for prolonged QT interval and associated outcomes in children with early restrictive eating patterns
Aim: This study aimed to describe the frequency of QTc prolongation in children with restrictive eating disorders early in the course of disease admitted for inpatient therapy, to determine the frequency of associated ventricular arrhythmia, and to evaluate the relationship between QTc interval and concomitant electrolyte abnormalities and rate of weight loss.Methods: This was a retrospective cohort study of patients aged 11–25 years with early restrictive eating disorders.Results: In all, 82 patients met the inclusion criteria (84% female). In total, 9.8% had prolonged QTc interval during hospitalisation. Patients with prolonged QTc had significantly higher resting heart rates (p=0.006), but there was no association with hypokalaemia (p=0.31), hypomagnesaemia (p=0.43), hypophosphataemia (p=1), or rate of weight loss (p=1).Conclusion: Mild QTc prolongation in patients with restrictive eating disorders is not related to electrolyte abnormalities or rate of weight loss in this population, suggesting that investigation about other potential risk factors of prolonged QTc interval may be warranted.
- 2 June 2015
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 26 (4) , 644-649
Risk for prolonged QT interval and associated outcomes in children with early restrictive eating patterns
Aim: This study aimed to describe the frequency of QTc prolongation in children with restrictive eating disorders early in the course of disease admitted for inpatient therapy, to determine the frequency of associated ventricular arrhythmia, and to evaluate the relationship between QTc interval and concomitant electrolyte abnormalities and rate of weight loss.Methods: This was a retrospective cohort study of patients aged 11–25 years with early restrictive eating disorders.Results: In all, 82 patients met the inclusion criteria (84% female). In total, 9.8% had prolonged QTc interval during hospitalisation. Patients with prolonged QTc had significantly higher resting heart rates (p=0.006), but there was no association with hypokalaemia (p=0.31), hypomagnesaemia (p=0.43), hypophosphataemia (p=1), or rate of weight loss (p=1).Conclusion: Mild QTc prolongation in patients with restrictive eating disorders is not related to electrolyte abnormalities or rate of weight loss in this population, suggesting that investigation about other potential risk factors of prolonged QTc interval may be warranted.
- 1 March 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (5) , 652-655
Usefulness of Ventricular Premature Complexes in Asymptomatic Patients ≤21 Years as Predictors of Poor Left Ventricular Function
- 1 March 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (5) , 652-655
Usefulness of Ventricular Premature Complexes in Asymptomatic Patients ≤21 Years as Predictors of Poor Left Ventricular Function
- 1 September 2013
- Published by Elsevier in Heart Rhythm
- Vol. 10 (9) , 1351-1353
Long QT genetics manifesting as atrial fibrillation
- 1 September 2013
- Published by Elsevier in Heart Rhythm
- Vol. 10 (9) , 1351-1353
Long QT genetics manifesting as atrial fibrillation